Social Media Ideas for Allergan V. Msn Laboratories

A Prescription for Liability- Injunction in Gray-Market Drug Case Based on Material Differences

Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award

A New York federal court confirmed an arbitrator's finding that Sun Pharmaceuticals breached an agreement with the owner of an acne drug by seeking regulatory approval to market a...

Practical Guidance for Pharmaceutical Method-of-Use Patent Claims After Teva v. Eli Lilly and In re Xencor

Pharmaceutical Method-of-Use Claims After Teva v. Eli Lilly and In re Xencor: Written Description, Enablement, and the K...

Biogen Must Face Pharmacies' MS Drug Monopoly Suit

An Illinois federal judge on Tuesday refused to dismiss Walgreens and Kroger's lawsuit accusing Biogen Inc. of illegally stifling competition for its multiple sclerosis drug Tecfid...

Preliminary Injunction Enjoins Trade Organization Plaintiff Group Against Enforcement under California’s “Truth in Label...

AbbVie Seeks Block On Alkem Generic Constipation Drug

AbbVie Inc. and collaborator Ironwood Pharmaceuticals urged a New Jersey federal court to bar India-based generic drugmaker Alkem Laboratories from selling generic versions of thei...

Court of Federal Claims Reaffirms Agency Discretion in TAA Country-of-Origin Determinations for Pharmaceuticals

On July 28, 2026, the U.S. Court of Federal Claims issued its decision in AvKare, LLC v. United States[1], upholding the Department of Veterans Affairs’ (“VA”) national contract aw...

Fed. Circ. Upholds Block On MSN Cancer Drug In Exelixis Win

The Federal Circuit on Monday rejected MSN Laboratories' argument that three Exelixis patents on the blockbuster cancer drug Cabometyx are invalid, while dismissing as moot an appe...

Bristol Myers Sues Generics Cos. Over Planned Cardiac Drug

Bristol Myers Squibb and MyoKardia have filed patent infringement suits in Delaware against a variety of pharmaceutical companies, including MSN Laboratories and Dr. Reddy's Labora...

One Atomic Substitution, Two Giant Hurdles of Disclosure and Efficacy

In Intra Cellular Therapies v. Controller of Patents, the Delhi High Court revisited two recurring fault lines in pharmaceutical patent law: the coverage disclosure distinction in...

Federal Circuit Affirms Non-Infringement Ruling in Lidocaine Patch Patent Dispute Over ZTlido Generic

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision Tuesday affirming a judgment of non-infringement entered by the U.S. District Court for the Southern Dist...

Sun Pharma withdraws multiple eye drop products as precautionary measure

Sun Pharma urged distributors to halt sales and return stocks while assuring patients of continued efforts to restore product availability

Eli Lilly Launches Attacks On Tirzepatide Generics

Eli Lilly and Co. fired off a round of lawsuits in Delaware federal court seeking to block generic versions of its tirzepatide weight loss and diabetes medications, targeting Sando...

DOJ's $46M Veloxis Settlement Signals Deeper Scrutiny of Pharma Referral Arrangements

Michigan Supreme Court Opens Door to Increased MCPA Enforcement: Key Takeaways from Eli Lilly

Eton's Galzin TM And False Ad Suit Survives Dismissal Bid

Eton Pharmaceuticals can proceed with trademark infringement and false advertising claims accusing Extreme V of marketing a dietary supplement as a Wilson disease treatment, with a...

<![CDATA[M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint...

<![CDATA[Sandoz Agrees to $450 Million Settlement With 43 US States Over Generic Drug Antitrust Claims]]>

FTC Reaches Second Insulin Pricing Settlement: Comparing the Caremark and ESI Orders

<![CDATA[Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons]]>

Court Ruling Dismisses Anaphylaxis Product Liability Claim

An Oklahoma federal court ruling underscores the high bar plaintiffs face when linking anaphylaxis to an allegedly defective consumer product. The post Court Ruling Dismisses Anaph...

3rd Circ. Upholds Dismissal Of Lipitor Pay-To-Delay Case

The Third Circuit on Thursday backed the dismissal of an antitrust suit alleging Pfizer Inc. and Ranbaxy Laboratories Ltd. conspired to delay the market entry of a generic version...

dsm-firmenich initiates patent infringement litigation in China regarding production of Sclareol via biotechnology

dsm-firmenich, innovators in nutrition, health, and beauty, has initiated patent infringement litigation before the Xiong'An New District Court of Hebei Province, China, against mu...